Haemonetics Past Earnings Performance
Past criteria checks 5/6
Haemonetics has been growing earnings at an average annual rate of 13.7%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 5.5% per year. Haemonetics's return on equity is 13.4%, and it has net margins of 10%.
Key information
13.7%
Earnings growth rate
13.8%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 5.5% |
| Return on equity | 13.4% |
| Net Margin | 10.0% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Haemonetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Dec 23 | 1,270 | 127 | 405 | 53 |
| 30 Sep 23 | 1,239 | 128 | 382 | 53 |
| 01 Jul 23 | 1,219 | 137 | 376 | 51 |
| 01 Apr 23 | 1,169 | 115 | 374 | 49 |
| 31 Dec 22 | 1,129 | 96 | 375 | 47 |
| 01 Oct 22 | 1,084 | 86 | 360 | 44 |
| 02 Jul 22 | 1,026 | 68 | 334 | 44 |
| 02 Apr 22 | 993 | 43 | 332 | 46 |
| 01 Jan 22 | 953 | 23 | 296 | 43 |
| 02 Oct 21 | 934 | 31 | 282 | 41 |
| 03 Jul 21 | 903 | 64 | 279 | 37 |
| 03 Apr 21 | 870 | 79 | 264 | 32 |
| 26 Dec 20 | 884 | 108 | 229 | 31 |
| 26 Sep 20 | 903 | 106 | 241 | 30 |
| 27 Jun 20 | 946 | 96 | 256 | 30 |
| 28 Mar 20 | 988 | 77 | 266 | 30 |
| 28 Dec 19 | 999 | 80 | 293 | 29 |
| 28 Sep 19 | 988 | 68 | 296 | 31 |
| 29 Jun 19 | 977 | 49 | 294 | 33 |
| 30 Mar 19 | 968 | 55 | 262 | 35 |
| 29 Dec 18 | 952 | 46 | 300 | 38 |
| 29 Sep 18 | 939 | 21 | 317 | 41 |
| 30 Jun 18 | 922 | 23 | 316 | 40 |
| 31 Mar 18 | 904 | 46 | 278 | 35 |
| 30 Dec 17 | 898 | -17 | 309 | 37 |
| 30 Sep 17 | 892 | 4 | 283 | 33 |
| 01 Jul 17 | 887 | 4 | 280 | 34 |
| 01 Apr 17 | 886 | -26 | 302 | 38 |
| 31 Dec 16 | 900 | 16 | 306 | 39 |
| 01 Oct 16 | 906 | -59 | 314 | 42 |
| 02 Jul 16 | 905 | -66 | 317 | 45 |
| 02 Apr 16 | 909 | -56 | 317 | 45 |
| 26 Dec 15 | 893 | -50 | 319 | 51 |
| 26 Sep 15 | 891 | 26 | 322 | 51 |
| 27 Jun 15 | 899 | 20 | 332 | 50 |
| 28 Mar 15 | 910 | 17 | 337 | 54 |
| 27 Dec 14 | 925 | 30 | 348 | 51 |
| 27 Sep 14 | 935 | 30 | 396 | 54 |
| 28 Jun 14 | 943 | 39 | 382 | 58 |
| 29 Mar 14 | 939 | 35 | 366 | 54 |
| 28 Dec 13 | 947 | 38 | 328 | 54 |
| 28 Sep 13 | 953 | 31 | 284 | 50 |
| 29 Jun 13 | 935 | 21 | 295 | 46 |
Quality Earnings: HAZ has high quality earnings.
Growing Profit Margin: HAZ's current net profit margins (10%) are higher than last year (8.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HAZ's earnings have grown by 13.7% per year over the past 5 years.
Accelerating Growth: HAZ's earnings growth over the past year (32.3%) exceeds its 5-year average (13.7% per year).
Earnings vs Industry: HAZ earnings growth over the past year (32.3%) exceeded the Medical Equipment industry -9.8%.
Return on Equity
High ROE: HAZ's Return on Equity (13.4%) is considered low.